Published in J Appl Physiol (1985) on January 07, 2005
Power of Choice on Exercise Adherence and Cardiovascular Health | NCT03576924
Effect of exercise intensity on abdominal fat loss during calorie restriction in overweight and obese postmenopausal women: a randomized, controlled trial. Am J Clin Nutr (2009) 1.77
Mortality trends in the general population: the importance of cardiorespiratory fitness. J Psychopharmacol (2010) 1.53
The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis (2013) 1.48
The future of obesity reduction: beyond weight loss. Nat Rev Endocrinol (2009) 1.42
Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction? Can J Cardiol (2008) 1.14
Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc (2015) 1.10
Exercise training reduces central adiposity and improves metabolic indices in HAART-treated HIV-positive subjects in Rwanda: a randomized controlled trial. AIDS Res Hum Retroviruses (2008) 1.07
Differential effects of aerobic exercise, resistance training and combined exercise modalities on cholesterol and the lipid profile: review, synthesis and recommendations. Sports Med (2014) 1.03
Non-Exercise Estimated Cardiorespiratory Fitness: Associations with Brain Structure, Cognition, and Memory Complaints in Older Adults. Ment Health Phys Act (2011) 0.98
Speeding of VO2 kinetics with endurance training in old and young men is associated with improved matching of local O2 delivery to muscle O2 utilization. J Appl Physiol (1985) (2010) 0.98
The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance. Eur J Appl Physiol (2005) 0.96
Chronic effects of superimposed electromyostimulation during cycling on aerobic and anaerobic capacity. Eur J Appl Physiol (2017) 0.96
Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PLoS One (2012) 0.94
Unique environmental effects on physical activity participation: a twin study. PLoS One (2008) 0.89
Individualized Exercise Training at Maximal Fat Oxidation Combined with Fruit and Vegetable-Rich Diet in Overweight or Obese Women: The LIPOXmax-Réunion Randomized Controlled Trial. PLoS One (2015) 0.84
[High intensity training (HIT) for the improvement of endurance capacity of recreationally active people and in prevention & rehabilitation]. Wien Med Wochenschr (2010) 0.84
Effects of Short-term Exercise Training on Cardiorespiratory Fitness of Male Adults with Myocardial Infarction. J Phys Ther Sci (2013) 0.82
Pathophysiology of Non Alcoholic Fatty Liver Disease. Int J Mol Sci (2016) 0.81
The effects of a graduated aerobic exercise programme on cardiovascular disease risk factors in the NHS workplace: a randomised controlled trial. J Occup Med Toxicol (2008) 0.81
Beneficial and harmful effects of exercise in hypertensive patients: the role of oxidative stress. Hypertens Res (2016) 0.81
Aerobic and anaerobic exercise training in obese adults. J Phys Ther Sci (2015) 0.81
Exercise training and habitual physical activity: a randomized controlled trial. Am J Prev Med (2012) 0.79
High versus moderate intensity running exercise to impact cardiometabolic risk factors: the randomized controlled RUSH-study. Biomed Res Int (2014) 0.78
High intensity training improves health and physical function in middle aged adults. Biology (Basel) (2014) 0.78
The Effects of Sprint Interval vs. Continuous Endurance Training on Physiological And Metabolic Adaptations in Young Healthy Adults. J Hum Kinet (2014) 0.78
Adherence, Compliance, and Health Risk Factor Changes following Short-Term Physical Activity Interventions. Biomed Res Int (2015) 0.77
Physical Activity and Lipid Profile in the ELSA- Brasil Study. Arq Bras Cardiol (2016) 0.77
Application of the speed-duration relationship to normalize the intensity of high-intensity interval training. PLoS One (2013) 0.76
Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study. BMC Complement Altern Med (2015) 0.76
The effects of intermittent exercise on physiological outcomes in an obese population: continuous versus interval walking. J Sports Sci Med (2010) 0.75
Exercise volume and aerobic fitness in young adults: the Midwest Exercise Trial-2. Springerplus (2016) 0.75
Why are some people more fit than others? Correlates and determinants of cardiorespiratory fitness in adults: protocol for a systematic review. Syst Rev (2017) 0.75
Diet Versus Exercise in Weight Loss and Maintenance: Focus on Tryptophan. Int J Tryptophan Res (2016) 0.75
The joint impact of smoking and exercise capacity on clinical outcomes among women with suspected myocardial ischemia: the WISE study. J Womens Health (Larchmt) (2009) 0.75
The effect of walking on fitness, fatness and resting blood pressure: a meta-analysis of randomised, controlled trials. Prev Med (2006) 3.25
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients. J Antimicrob Chemother (2008) 2.52
Could the correlation between maximal oxygen uptake and "ECONOMY" be spurious? Med Sci Sports Exerc (2003) 2.16
Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis (2009) 1.81
Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy. Clin Infect Dis (2012) 1.76
The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood (2013) 1.62
Development of a transactivator in hepatoma cells that allows expression of phase I, phase II, and chemical defense genes. Am J Physiol Cell Physiol (2005) 1.59
HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms. Pharmacogenet Genomics (2010) 1.57
Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. Pharmacogenet Genomics (2012) 1.50
The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications. Antimicrob Agents Chemother (2011) 1.49
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategies. J Acquir Immune Defic Syndr (2013) 1.46
Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis (2007) 1.46
Evidence-based use of serum protein electrophoresis in laboratory medicine. Clin Chem Lab Med (2013) 1.44
Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. Br J Haematol (2007) 1.41
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer (2011) 1.38
Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil (2009) 1.30
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother (2011) 1.26
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir. Clin Infect Dis (2008) 1.22
Acridinediones: selective and potent inhibitors of the malaria parasite mitochondrial bc1 complex. Mol Pharmacol (2008) 1.22
Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP. AIDS (2005) 1.20
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. J Infect Dis (2011) 1.18
The effect of a worksite based walking programme on cardiovascular risk in previously sedentary civil servants [NCT00284479]. BMC Public Health (2006) 1.17
Host determinants of antiretroviral drug activity. Curr Opin Infect Dis (2005) 1.16
Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies. Clin Cancer Res (2013) 1.12
The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. J Acquir Immune Defic Syndr (2003) 1.12
Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome. J Clin Oncol (2012) 1.09
Underweight and obese states both associate with worse disease activity and physical function in patients with established rheumatoid arthritis. Clin Rheumatol (2008) 1.08
Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals. J Antimicrob Chemother (2011) 1.06
Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein. Tuberculosis (Edinb) (2007) 1.04
Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother (2007) 1.04
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob Agents Chemother (2010) 1.03
Bioaccessibility and excretion of arsenic in Niu Huang Jie Du Pian pills. Toxicol Appl Pharmacol (2006) 1.02
Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells. Blood (2013) 1.02
New approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agents. Drugs (2014) 1.01
Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort. PLoS One (2011) 0.98
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir. Antimicrob Agents Chemother (2010) 0.98
Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother (2009) 0.98
Exon sequencing and high resolution haplotype analysis of ABC transporter genes implicated in drug resistance. Pharmacogenet Genomics (2006) 0.97
Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine. Antimicrob Agents Chemother (2013) 0.96
Sequence and gene expression of chloroquine resistance transporter (pfcrt) in the association of in vitro drugs resistance of Plasmodium falciparum. Malar J (2011) 0.96
The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance. Eur J Appl Physiol (2005) 0.96
Activity levels, dietary energy intake, and body composition in children who walk to school. Pediatr Exerc Sci (2007) 0.95
Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res Ther (2011) 0.94
Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg. J Antimicrob Chemother (2011) 0.94
Incident diabetes in clinical trials of antihypertensive drugs. Lancet (2007) 0.93
The mechanisms that control intracellular penetration of the HIV protease inhibitors. J Antimicrob Chemother (2003) 0.93
Physiologically Based Pharmacokinetic Modelling to Inform Development of Intramuscular Long-Acting Nanoformulations for HIV. Clin Pharmacokinet (2015) 0.93
HFNEF breathlessness: is it really heart failure? Int J Cardiol (2010) 0.93
Body dissatisfaction, body fat and physical activity in British children. Int J Pediatr Obes (2006) 0.93
Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol (2011) 0.91
Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding. Pharmacogenomics (2012) 0.90
Statins moderate coronary stenoses but not coronary calcification: results from meta-analyses. Int J Cardiol (2010) 0.90
Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure. Antimicrob Agents Chemother (2008) 0.90
Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals. Antimicrob Agents Chemother (2012) 0.89
Vitamin D status in professional ballet dancers: winter vs. summer. J Sci Med Sport (2013) 0.88
Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients. J Antimicrob Chemother (2013) 0.88
Tako-Tsubo syndrome in an anaesthetised patient undergoing arthroscopic knee surgery. Ann Card Anaesth (2008) 0.88
Antiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlation. Adv Healthc Mater (2013) 0.87
Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care (2013) 0.87
Mitochondria are sensors for HIV drugs. Trends Pharmacol Sci (2005) 0.87
The reproducibility of 31-phosphorus MRS measures of muscle energetics at 3 Tesla in trained men. PLoS One (2012) 0.87
Determinants of 800-m and 1500-m running performance using allometric models. Med Sci Sports Exerc (2008) 0.87
Does doing housework keep you healthy? The contribution of domestic physical activity to meeting current recommendations for health. BMC Public Health (2013) 0.87
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. Pharmacogenet Genomics (2010) 0.87
Differences in physical activity levels between white and South Asian children in the United Kingdom. Pediatr Exerc Sci (2008) 0.87
Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach. Clin Pharmacokinet (2013) 0.87
Cigarette smoking associates with body weight and muscle mass of patients with rheumatoid arthritis: a cross-sectional, observational study. Arthritis Res Ther (2008) 0.85
Estimation of the effect of SLCO1B1 polymorphisms on lopinavir plasma concentration in HIV-infected adults. Antivir Ther (2012) 0.85
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res (2004) 0.85
Mediation of in vitro cytochrome p450 activity by common pharmaceutical excipients. Mol Pharm (2013) 0.85
Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohort. J Antimicrob Chemother (2010) 0.85
Changes in the angle-force curve of human elbow flexors following eccentric and isometric exercise. Eur J Appl Physiol (2004) 0.84
Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharmacol (2013) 0.84
Correlates of efavirenz exposure in Chilean patients affected with human immunodeficiency virus reveals a novel association with a polymorphism in the constitutive androstane receptor. Ther Drug Monit (2013) 0.84
Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients. Am J Clin Pathol (2013) 0.84
Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy. PLoS One (2013) 0.84
Congratulations to team GB, but why should we be so surprised? Olympic medal count can be predicted using logit regression models that include 'home advantage'. Br J Sports Med (2012) 0.83
The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein. Biochem Biophys Res Commun (2011) 0.83
Ambulatory physical activity levels of white and South Asian children in Central England. Acta Paediatr (2012) 0.83
Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expression. Transplantation (2004) 0.83
Intracellular 'boosting' of darunavir using known transport inhibitors in primary PBMC. Br J Clin Pharmacol (2009) 0.83
Effects of a 6-week circuit training intervention on body esteem and body mass index in British primary school children. Body Image (2009) 0.83
Divalent metals and pH alter raltegravir disposition in vitro. Antimicrob Agents Chemother (2012) 0.83
Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells. Acta Pharmacol Sin (2010) 0.82
Scaling behaviour of VO2 in athletes and untrained individuals. Ann Hum Biol (2007) 0.82
Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients. Clin Pharmacokinet (2013) 0.82
CYP3A4*22 (c.522-191 C>T; rs35599367) is associated with lopinavir pharmacokinetics in HIV-positive adults. Pharmacogenet Genomics (2014) 0.82
Acute Effects of Vitamin D3 Supplementation on Muscle Strength in Judoka Athletes: A Randomized Placebo-Controlled, Double-Blind Trial. Clin J Sport Med (2016) 0.81
Method of lactate elevation does not affect the determination of the lactate minimum. Med Sci Sports Exerc (2002) 0.81
Body esteem and body fat in British school children from different ethnic groups. Body Image (2004) 0.81
CYP2B6 516G>T (rs3745274) and smoking status are associated with efavirenz plasma concentration in a Serbian cohort of HIV patients. Ther Drug Monit (2014) 0.81
Toward greener dialysis: a case study to illustrate and encourage the salvage of reject water. J Ren Care (2010) 0.81
Lopinavir/ritonavir single agent therapy as a universal combination antiretroviral therapy stopping strategy: results from the STOP 1 and STOP 2 studies. J Antimicrob Chemother (2011) 0.81
Early valve replacement for aortic stenosis irrespective of symptoms results in better clinical survival: a meta-analysis of the current evidence. Int J Cardiol (2013) 0.80
No relationship between drug transporter genetic variants and tenofovir plasma concentrations or changes in glomerular filtration rate in HIV-infected adults. J Acquir Immune Defic Syndr (2015) 0.80